Publications

Title

Author

Year

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.

Lin, MY; Geluk, A; SMITH, SG; Stewart, AL; Friggen, AH; Franken, KL M C; Verduyn, MJ C; Van Meijgaarden, KE; Voskuil, MI; DOCKRELL, HM; Huygen, K; Ottenhoff, TH M; Klein, MR;

2007

Infection and immunity, (2007).75 7 10.1128/IAI.01999-06.

UK preparedness for pandemic influenza.

COKER, R;

2007

BMJ (Clinical research ed), (2007).334 7601 10.1136/bmj.39205.591389.80.

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study.

Grassly, NC; Wenger, J; Durrani, S; Bahl, S; Deshpande, JM; Sutter, RW; HEYMANN, DL; Aylward, RB;

2007

Lancet, (2007).369 9570 10.1016/S0140-6736(07)60531-5.

Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa?.

CHANDRAMOHAN, D; WEBSTER, J; Smith, L; Awine, T; OWUSU-AGYEI, S; CARNEIRO, I;

2007

Tropical medicine & international health, (2007).12 6 10.1111/j.1365-3156.2007.01844.x.

Cost-effectiveness analyses of human papillomavirus vaccination.

Newall, AT; Beutels, P; Wood, JG; EDMUNDS, WJ; MacIntyre, CR;

2007

The Lancet infectious diseases, (2007).7 4 10.1016/S1473-3099(07)70083-X.

New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.

Wong, S; Lennon, D; Jackson, C; Stewart, J; Reid, S; Crengle, S; Tilman, S; Aaberge, I; O'Hallahan, J; Oster, P; MULHOLLAND, K; Martin, D;

2007

The Pediatric infectious disease journal, (2007).26 4 10.1097/01.inf.0000258697.05341.2c.

Safety and immunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthetic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa.

Sirima, SB; Nébié, I; Ouédraogo, A; Tiono, AB; Konaté, AT; Gansané, A; Dermé, AI; Diarra, A; Ouédraogo, A; Soulama, I; Cuzzin-Ouattara, N; COUSENS, S; Leroy, O;

2007

Vaccine, (2007).25 14 10.1016/j.vaccine.2006.05.090.

Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Aguirre-Blanco, AM; Lukey, PT; CLIFF, JM; DOCKRELL, HM;

2007

Infection and immunity, (2007).75 6 10.1128/IAI.01611-06.

The preventable burden of pneumococcal disease in the developing world.

SCOTT, JA G;

2007

Vaccine, (2007).25 13 10.1016/j.vaccine.2006.09.008.

Modeling rotavirus-like particles production in a baculovirus expression vector system: Infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production.

Roldão, A; Vieira, HL A; Charpilienne, A; Poncet, D; ROY, P; Carrondo, MJ T; Alves, PM; Oliveira, R;